Last reviewed · How we verify
NCT04979026
Clinical Investigation of a Novel Approach for the Prevention of Deep Venous Thrombosis After Total Knee Replacement
NA trial testing active ankle pumping with a regular watch alarm in Deep Venous Thrombosis in 90 participants. Completed in 31 December 2020.
20 November 2020
Quick facts
| Lead sponsor | Show Chwan Memorial Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 90 |
| Start date | 17 October 2019 |
| Primary completion | 20 November 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- active ankle pumping with a regular watch alarm
- intermittent pneumatic compression
Conditions studied
- Deep Venous Thrombosis — all drugs for Deep Venous Thrombosis →
Sponsor
Show Chwan Memorial Hospital
Who can join
Adults 40 to 90, any sex, with Deep Venous Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Venous thromboembolism, including deep vein thrombosis (DVT), has long been recognized as the most frequent complication within 7 to 14 days after orthopedic surgery, especially total joint arthroplasty. Without prophylactic therapy, the incidence of DVT and pulmonary embolism reaches up to 60% following orthopedic surgery. The possible damage to the vessel wall during the operation, the venous stasis caused by long-term bed rest, and the hypercoagulability of the blood after the surgery are the 3 main reasons for the formation of DVT. In most cases, the thrombi resolve spontaneously; however, some of them (about 1\~4%) may develop into symptomatic and even fatal DVT. Ankle pumping exercise is currently suggested for the patients with joint placement surgery to prevent the formation of lower-extremity DVT after orthopedic surgery. However, the compliance of the exercise at home is unclear. In order to remind the patients to the active ankle exercise and record the executive rate, a device was developed to help the patient to exercise in the hospital and at home. The device will remind the patient to exercise at specific time point by verbal and vibrations, and detect the range of motion during the exercise for further analysis. The aim of this study is to access the effect of a non-invasive novel device in preventing the formation of lower limb DVT. Maximum venous outflow, maximum venous capacity, and blood rheology were measured and the incidence of DVT was recorded for the data analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04979026
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Deep Venous Thrombosis
Currently open trials in the same condition.
- NCT07399977 — Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism · NA · recruiting
- NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
- NCT06913595 — Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery · Phase 1 · active not recruiting
- NCT05701917 — DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis · NA · recruiting
- NCT04924322 — Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies · Phase 2, PHASE3 · recruiting
Other Show Chwan Memorial Hospital trials
Trials by the same sponsor.
- NCT05264649 — Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With · NA · unknown
- NCT05023122 — The Effect of Oral Vitamin D Supplements on Fusion Outcome in Patients Receiving Elective Lumbar Spinal Fusion · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04979026 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Show Chwan Memorial Hospital
- Last refreshed: 27 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04979026.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing